FTSE boosted by pharmaceutical ruling

The FTSE 100 Index received a much-needed shot in the arm today when a ruling on a blockbuster drug boosted shares in pharmaceutical firms.

Both AstraZeneca and rival GlaxoSmithKline made strong gains after American regulators said AstraZeneca’s cholesterol-lowering drug Crestor was not more likely to cause muscle damage than similar treatments.